Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 874.19% | 440.02% | 101.50% | 99.36% | 99.75% |
| Total Depreciation and Amortization | -8.23% | -5.12% | 7.26% | -7.73% | -13.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.37% | 2.79% | -95.51% | -93.06% | -94.50% |
| Change in Net Operating Assets | 930.61% | -172.23% | -86.66% | -107.10% | -110.49% |
| Cash from Operations | 46.67% | -8.50% | -11.68% | 1.18% | -15.53% |
| Capital Expenditure | 35.88% | 23.51% | 10.85% | 15.45% | -36.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 39.35% | 27.76% | -25.24% | 95.28% | 94.36% |
| Total Debt Issued | 919.05% | 46.33% | 46.33% | -25.59% | -92.73% |
| Total Debt Repaid | -244.29% | -15.92% | -25.72% | -26.91% | 60.33% |
| Issuance of Common Stock | -- | -- | 638.55% | 638.55% | 638.55% |
| Repurchase of Common Stock | -3.64% | -139.23% | -167.58% | -167.58% | -167.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.61% | -1.59% | -1.36% | -1.13% | -0.78% |
| Other Financing Activities | 101.06% | -1,992.92% | -527.90% | -408.03% | -642.48% |
| Cash from Financing | -0.94% | 5.97% | -2.52% | -243.18% | -232.13% |
| Foreign Exchange rate Adjustments | -84.34% | 43.84% | 12,342.86% | 27.24% | 1,888.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.91% | 55.99% | -172.51% | 65.29% | -84.25% |